PRESENTATION TITLE:
What's New In Heart Failure

PRESENTER(S):
Paul McKie, M.D.

LEARNING OBJECTIVES:

• Summarize outcomes data for SGLT-2 inhibitors and angiotensin receptor / neprilysin inhibitors in heart failure.
• Compare the benefits of new medical therapy to established medical therapy.
• Develop pragmatic strategies to incorporate new heart failure medical therapies into your practice. 

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.